Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperuricemia and Cardiovascular Disease
Shuangshuang Zhang, Yong Wang, Jinsong Cheng, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 6, pp. 700-709
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Hyperuricemia and its related diseases: mechanisms and advances in therapy
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 75
PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review)
Daniela Miricescu, Daniela Bălan, Adrian Tulin, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 78
Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
Tzong‐Shyuan Lee, Tse-Min Lu, Chia‐Hui Chen, et al.
Redox Biology (2021) Vol. 46, pp. 102108-102108
Open Access | Times Cited: 60
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway
Yanlu Liu, Shiting Gong, Kejian Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113941-113941
Open Access | Times Cited: 51
Amelioration effects of α-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice
Xiaoli Guo, Yanyan Gao, Ya-Xin Yang, et al.
Phytomedicine (2023) Vol. 116, pp. 154868-154868
Open Access | Times Cited: 27
Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications
Bimei Song, Yue Zeng, Yanqing Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Enhanced reproductive toxicity of photodegraded polylactic acid microplastics in zebrafish
Liwen Zhang, Yuxuan Luo, Zheng Zhang, et al.
The Science of The Total Environment (2023) Vol. 912, pp. 168742-168742
Closed Access | Times Cited: 24
Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice
Yukun Li, Hanqing Li, Rong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114568-114568
Open Access | Times Cited: 22
The relationship between serum uric acid level and non-alcoholic fatty liver disease in northern China: a retrospective cohort study
Qianjun He, Xinyue Liu, Guoyong Ding, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Effectiveness of targeting the NLRP3 inflammasome by using natural polyphenols: A systematic review of implications on health effects
Taotao Wang, Hong Xu, Ruixia Dong, et al.
Food Research International (2023) Vol. 165, pp. 112567-112567
Closed Access | Times Cited: 20
Exploration of the anti-hyperuricemia effect of TongFengTangSan (TFTS) by UPLC-Q-TOF/MS-based non-targeted metabonomics
Zhichao Huang, Wugang Zhang, Qiong An, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS/NLRP3 pathway
Bin He, Qiangqiang Nie, Feng Wang, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 8, pp. 1808-1822
Closed Access | Times Cited: 16
Higher Atherogenic Index of Plasma Is Associated with Hyperuricemia: A National Longitudinal Study
Feifei Xu, Chengyong Ma, Shouping Wang, et al.
International Journal of Endocrinology (2024) Vol. 2024, pp. 1-12
Open Access | Times Cited: 6
Impact of adipose tissue in chronic kidney disease development (Review)
Daniela Miricescu, Daniela Bălan, Adrian Tulin, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 37
Prevalence of hyperuricemia and the population attributable fraction of modifiable risk factors: Evidence from a general population cohort in China
Huijing He, Pei Guo, Jiangshan He, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 24
Research Progress of Natural Active Substances with Uric-Acid-Reducing Activity
Xin Zhang, Jie Cui, Junling Hou, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 50, pp. 15647-15664
Closed Access | Times Cited: 22
Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout
Zihan Hou, Aijinxiu Ma, Jiale Mao, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 895-909
Closed Access | Times Cited: 14
Smartphone-assisted colorimetric detection of uric acid based on the enhanced peroxidase-like activity of Cu doping Prussian blue
Liuyan Wei, Ying Yang, Hailin Zhang, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2025) Vol. 333, pp. 125898-125898
Closed Access
Integration of metabolomics and genomics implicates a causality between 1398 blood metabolites and gout
Mingyuan Fan, Zhangjun Yun, Jiushu Yuan, et al.
Clinical Rheumatology (2025)
Closed Access
Meta-analysis of the correlation between serum uric acid level and carotid intima-media thickness
Mingzhu Ma, Liangxu Wang, Wenjing Huang, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246416-e0246416
Open Access | Times Cited: 31
Resveratrol affects the expression of uric acid transporter by improving inflammation
Xuemei Zhang, Qian Nie, Zhimei Zhang, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 2
Open Access | Times Cited: 27
Association of Visceral Fat Area and Hyperuricemia in Non-Obese US Adults: A Cross-Sectional Study
Zhiying Li, Lijie Gao, Xiaoqing Zhong, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 3992-3992
Open Access | Times Cited: 21
Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease
Jiaxin Qi, Xiayu Ren, Yanjuan Hou, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1323-1334
Open Access | Times Cited: 11
Nonlinearity association between hyperuricemia and all-cause mortality in patients with chronic kidney disease
Yafei Liu, Liang Han, Yin-Hong Geng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Impact of urate-lowering therapy on the course of chronic kidney disease in patients with asymptomatic hyperuricemia: a meta-analysis of randomized controlled trials
Mazurov Vi, Sergey A. Sayganov, Martynov Ai, et al.
HERALD of North-Western State Medical University named after I I Mechnikov (2024) Vol. 15, Iss. 4, pp. 5-18
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top